Get the Stockscreener App
8.04
2.94%
0.23
After Hours:
8.04
Journey Medical Corp stock is traded at $8.04, with a volume of 45,391.
It is up +2.94% in the last 24 hours and down -4.51% over the past month.
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
See More
Previous Close:
$7.81
Open:
$7.91
24h Volume:
45,391
Relative Volume:
0.36
Market Cap:
$267.38M
Revenue:
$56.13M
Net Income/Loss:
$-14.67M
P/E Ratio:
-10.86
EPS:
-0.74
Net Cash Flow:
$-9.13M
1W Performance:
-7.85%
1M Performance:
-4.51%
6M Performance:
+13.88%
1Y Performance:
+58.42%
1-Day Range:
$7.78
$8.30
1-Week Range:
$7.78
$8.76
52-Week Range:
$4.97
$9.555
Journey Medical Corp Stock (DERM) Company Profile
Name
Journey Medical Corp
Sector
Phone
480-434-6670
Address
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Compare DERM vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
8.04 | 259.73M | 56.13M | -14.67M | -9.13M | -0.74 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
125.96 | 53.16B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.47 | 47.25B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.91 | 37.59B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
490.21 | 21.85B | 3.13B | 1.27B | 1.12B | 26.39 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Initiated | H.C. Wainwright | Buy |
| Jul-30-25 | Resumed | B. Riley Securities | Buy |
| Aug-22-24 | Initiated | Rodman & Renshaw | Buy |
| Jun-28-24 | Resumed | ROTH MKM | Buy |
| Dec-07-21 | Initiated | B. Riley Securities | Buy |
Journey Medical Corp Stock (DERM) Latest News
Rally Mode: Will Journey Medical Corporation benefit from sector rotationJuly 2025 Macro Moves & Entry Point Confirmation Alerts - baoquankhu1.vn
Journey Medical (NASDAQ:DERM) Shares Down 3.5%What's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: ClearPoint Neuro (CLPT) and Journey Medical Corp (DERM) - The Globe and Mail
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
DERM PE Ratio & Valuation, Is DERM Overvalued - Intellectia AI
Support Test: Will RLX Technology Inc Depositary Receipt stock hit new highs in YEARJuly 2025 Outlook & Community Verified Watchlist Alerts - baoquankhu1.vn
Why ORGO stock attracts high net worth investorsNew Guidance & Stock Portfolio Risk Control - mfd.ru
US Market Wrap: Does Senseonics Holdings Inc have declining or rising EPSQuarterly Growth Report & Community Trade Idea Sharing Platform - baoquankhu1.vn
Analyst Calls: Will Safety Shot Inc outperform the market in YEARJuly 2025 Opening Moves & Daily Profit Focused Stock Screening - baoquankhu1.vn
What’s the RSI of RVYL stockWeekly Trend Recap & Smart Swing Trading Techniques - mfd.ru
How buybacks impact GMAB stock valueQuarterly Portfolio Review & AI Driven Stock Price Forecasts - mfd.ru
DERM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
DERM Should I Buy - Intellectia AI
Gates Industrial (NYSE:GTES) Sets New 52-Week High Following Earnings Beat - Defense World
Journey Medical Corporation (NASDAQ:DERM) Receives $12.17 Consensus Target Price from Brokerages - Defense World
Buyout Rumor: Can Journey Medical Corporation be recession proofJuly 2025 Chart Watch & High Accuracy Swing Trade Signals - baoquankhu1.vn
Insurer Seeks To Cap Coverage In $3M Medical Transport Row - Law360
Insurer Seeks To Cap Coverage In $3M Medical Transit Row - Law360
Essex Investment Management Co. LLC Acquires 125,818 Shares of Journey Medical Corporation $DERM - MarketBeat
Tetracyclines Market is Poised to Garner Valuation of USD 5.63 Billion by 2035 | Astute Analytica - GlobeNewswire Inc.
Journey Medical Corporation (NASDAQ:DERM) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Journey Medical (NASDAQ:DERM) Shares Down 3.7%Here's What Happened - MarketBeat
Patient journey goes digital at Ewha Womans Seoul Hospital - Healthcare IT News
B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target - Investing.com Nigeria
B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target By Investing.com - Investing.com South Africa
10 Best Travel Insurance Companies For 2026 - Forbes
Will Journey Medical Corporation benefit from geopolitical trendsPortfolio Update Summary & Growth Oriented Trading Recommendations - mfd.ru
Value Recap: Can Journey Medical Corporation reach all time highs this year - baoquankhu1.vn
Risk Analysis: Is DUKPRA impacted by rising ratesMarket Risk Report & Community Supported Trade Ideas - baoquankhu1.vn
CVS Health Corp.: How a Pharmacy Giant Is Rebooting Itself as a Healthcare Platform - AD HOC NEWS
Journey Medical Corp entered into sales agreement to offer and sell up to 3.75 million shares of common stock - marketscreener.com
Journey Medical Corp Entered Into Sales Agreement To Offer And Sell Up To 3.75 Million Shares Of Common Stock - TradingView
Journey Medical: Emrosi Is Winning, But The Stock Hasn't Noticed - Seeking Alpha
Published on: 2026-01-20 22:55:08 - baoquankhu1.vn
Does Autonomix Medical Inc meet Warren Buffetts criteriaJuly 2025 Summary & Detailed Earnings Play Alerts - baoquankhu1.vn
Published on: 2026-01-19 20:20:55 - baoquankhu1.vn
Journey Medical Corp: Small-Cap Dermatology Stock Walks a Tightrope Between Turnaround Hopes and Vol - AD HOC NEWS
Is Cerus Corporation being accumulated by smart money2025 Volume Leaders & High Accuracy Investment Signals - baoquankhu1.vn
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of “Hold” by Analysts - Defense World
Journey Medical Files $150 Million Mixed Shelf - marketscreener.com
Journey Medical (NASDAQ:DERM) Trading 3.4% HigherHere's What Happened - MarketBeat
WebMD Launches Embody -- A Whole-Self Health, Weight Loss, and Weight Management Platform - The AI Journal
Early ZYCUBO treatment cut death risk nearly 80% in children with Menkes - Stock Titan
CVS Health Corp.: How a Pharmacy Giant Is Re?Engineering the Front Door to U.S. Healthcare - AD HOC NEWS
Axillary Hyperhidrosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Botanix Pharma, Sound Surgical Tech, Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corp. - Barchart.com
Journey Medical (DERM) Publishes Positive Emrosi Phase 1 Microbiome Data - MSN
Will Journey Medical Corporation stock gain from government policiesJuly 2025 Retail & AI Enhanced Trading Signals - Улправда
Is Microbot Medical Inc. (CY9D) stock vulnerable to rate hikesWeekly Stock Report & Weekly High Return Opportunities - ulpravda.ru
Can Tenon Medical Inc. Equity Warrant stock hit record highs againJuly 2025 Retail & Weekly Hot Stock Watchlists - Улправда
Why Orthofix Medical Inc. (OM2) stock is upgraded to buyAnalyst Upgrade & Safe Capital Growth Tips - Улправда
Journey Medical Corp Stock (DERM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.21%
1.77%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):